Literature DB >> 7862940

Caffeine enhances the stimulant effect of methamphetamine, but may not affect induction of methamphetamine sensitization of ambulation in mice.

H Kuribara1.   

Abstract

Methamphetamine (MAP: 1 and 2 mg/kg SC) and caffeine (CAF: 1, 3, 10 and 30 mg/kg SC) dose-dependently increased ambulation in mice. Repeated administration (5 times at 3 to 4-day intervals) of MAP, but not CAF, induced sensitization to its effect. Furthermore, the mice repeatedly receiving CAF showed no significant change in the sensitivity to MAP. Combined administration of MAP with CAF increased the effect. In the combinations of MAP (1 mg/kg) with CAF (3, 10 and 30 mg/kg), and MAP (2 mg/kg) with CAF (1 and 3 mg/kg), the effect was enhanced by the repeated administration. However, MAP sensitization was not modified by the combination with CAF in the repeated administration schedule, except in the combination of MAP (1 mg/kg) with CAF (30 mg/kg). The ambulation-increasing effects of MAP (1 mg/kg), CAF (10 mg/kg) and combination of MAP with CAF were almost equivalently inhibited by SCH 23390 (0.01 and 0.1 mg/kg SC) and YM-09151-2 (0.01 and 0.1 mg/kg SC). However, the inhibitory effects of apomorphine (0.05 mg/kg SC) and N6-(L-phenylisopropyl)-adenosine (0.1 and 0.2 mg/kg SC) were stronger for CAF than for MAP and the combination, and those of alpha-methyl-p-tyrosine (200 mg/kg IP, 4 h before) and reserpine (1 mg/kg SC, 4 h before) were stronger for MAP and CAF alone than for the combination. The present results suggest that, although the combination of MAP and CAF enhances the ambulation-increasing effect through an interaction at dopaminergic system, CAF may not significantly modify the induction of MAP sensitization in mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7862940     DOI: 10.1007/bf02245053

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

Review 1.  [Modification of the behavioral effects of drugs after repeated administration--special reference to the reverse tolerance of amphetamines].

Authors:  S Tadokoro; H Kuribara
Journal:  Nihon Yakurigaku Zasshi       Date:  1990-05

2.  Reverse tolerance to ambulation-increasing effects of methamphetamine and morphine in 6 mouse strains.

Authors:  H Kuribara; S Tadokoro
Journal:  Jpn J Pharmacol       Date:  1989-02

3.  Reverse tolerance to the ambulation-increasing effect of methamphetamine in mice as an animal model of amphetamine-psychosis.

Authors:  S Tadokoro; H Kuribara
Journal:  Psychopharmacol Bull       Date:  1986

4.  Evolving behavior in the clinical and experimental amphetamine (model) psychosis.

Authors:  E H Ellinwood; A Sudilovsky; L M Nelson
Journal:  Am J Psychiatry       Date:  1973-10       Impact factor: 18.112

5.  Selective binding of YM-09151-2, a new potent neuroleptic, to D2-dopaminergic receptors.

Authors:  M Terai; S Usuda; I Kuroiwa; O Noshiro; H Maeno
Journal:  Jpn J Pharmacol       Date:  1983-08

6.  SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions.

Authors:  R B Mailman; D W Schulz; M H Lewis; L Staples; H Rollema; D L Dehaven
Journal:  Eur J Pharmacol       Date:  1984-05-18       Impact factor: 4.432

7.  Caffeine tolerance: behavioral, electrophysiological and neurochemical evidence.

Authors:  D T Chou; S Khan; J Forde; K R Hirsh
Journal:  Life Sci       Date:  1985-06-17       Impact factor: 5.037

8.  Complete, reversible, drug-specific tolerance to stimulation of locomotor activity by caffeine.

Authors:  S G Holtzman
Journal:  Life Sci       Date:  1983-08-22       Impact factor: 5.037

9.  Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice.

Authors:  S Ferré; M Herrera-Marschitz; M Grabowska-Andén; M Casas; U Ungerstedt; N E Andén
Journal:  Eur J Pharmacol       Date:  1991-01-03       Impact factor: 4.432

10.  Adenosine receptors and behavioral actions of methylxanthines.

Authors:  S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

View more
  4 in total

1.  The adenosine receptor antagonist CGS15943 reinstates cocaine-seeking behavior and maintains self-administration in baboons.

Authors:  Elise M Weerts; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2003-04-01       Impact factor: 4.530

2.  Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice.

Authors:  Chih W Hsu; C Y Chen; Chin-Shine Wang; Ted H Chiu
Journal:  Psychopharmacology (Berl)       Date:  2009-01-24       Impact factor: 4.530

3.  Unusual effects of nicotine as a psychostimulant on ambulatory activity in mice.

Authors:  Toyoshi Umezu
Journal:  ISRN Pharmacol       Date:  2012-03-20

4.  Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid Barrier.

Authors:  Kei Ikeda-Murakami; Naoto Tani; Tomoya Ikeda; Yayoi Aoki; Takaki Ishikawa
Journal:  Int J Mol Sci       Date:  2022-02-07       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.